Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

VAUGHAN, Ontario -- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chief Financial Officer Sam Eldessouky is scheduled to participate in the 2025 Jefferies Global Healthcare Conference in New York City on June 4, 2025, at 7:35 a.m. ET.

Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in the US

LUMIFY eye drops were initially introduced by Bausch + Lomb in 2018 and remain the only OTC redness relievers that selectively target eye redness with a lower risk of rebound redness and loss of efficacy when used as directed.

Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in US

The OTC eye drops contain low-dose brimonidine tartrate 0.025%.

Bausch + Lomb unveils new LUMIFY Preservative Free redness reliever eye drops

VAUGHAN, Ontario — Bausch + Lomb Corp. announced the U.S. launch of LUMIFY Preservative Free redness reliever eye drops, the first and only preservative-free over-the-counter eye drops with low-dose brimonidine tartrate 0.025% that relieve redness of the eye due to minor eye irritations.“Consumers often say how amazed they are at the difference our original LUMIFY makes to their eyes, with over 50,000 five-star reviews as proof,” said John Ferri…